Your Messages Inbox
Your Article Summary
See Latest ArticlesRoche Discontinues and Plans to Delist Accutane in the U.S.
Roche, 07/01/09
Hoffmann-La Roche Inc. has notified the U.S. Food and Drug Administration of its intent to immediately discontinue the manufacture and distribution of Accutane, its ground-breaking treatment for severe recalcitrant nodular acne that has not responded to other therapies. This decision is being taken for business reasons during a reevaluation of our product portfolio of medicines that are now available from generic manufacturers, and is not being taken for reasons of safety or efficacy.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Review calls for EHR action in Saskatchewan
Canadian Healthcare Technology, 11/20/09
New Drug Application Filed for Eldecalcitol, An Active Vitamin D3 Derivative
Chugai Pharmaceutical Co., 11/04/09
Article Search
Sponsor